Macau, Macao

Li-Yu Chen

This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li-Yu Chen. Retrieved from https://idiyas.com/inventor/li-yu-chen-ftteesrz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Li-Yu Chen

Introduction

Li-Yu Chen is a notable inventor based in Macau, MO. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that can regulate immune cell activity. Her work has implications for cancer diagnosis and treatment.

Latest Patents

Li-Yu Chen holds a patent for "Anti-human TIM-3 antibodies and methods of use thereof." This patent describes an anti-human T-cell immunoglobulin domain and mucin domain 3 (TIM-3) antibody that can bind to specific peptides of the human TIM-3 protein. The antibody is particularly useful in the diagnosis, prognosis, and treatment of various cancers, including lung, liver, and esophageal cancer, as well as solid tumors.

Career Highlights

Li-Yu Chen is associated with the Development Center for Biotechnology, where she has been instrumental in advancing research in immunology and cancer treatment. Her innovative approaches have garnered attention in the scientific community.

Collaborations

Li-Yu Chen has collaborated with esteemed colleagues such as Chien-Tsun Kuan and Chung-Hsiun Wu. These partnerships have further enhanced her research and development efforts in biotechnology.

Conclusion

Li-Yu Chen's contributions to the field of biotechnology, particularly through her patent on TIM-3 antibodies, highlight her role as an influential inventor. Her work continues to pave the way for advancements in cancer treatment and diagnosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…